Dexcom Inc Stock Price History

DXCM Stock  USD 66.06  0.15  0.23%   
Below is the normalized historical share price chart for DexCom Inc extending back to April 14, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DexCom stands at 66.06, as last reported on the 20th of December, with the highest price reaching 66.87 and the lowest price hitting 65.64 during the day.
IPO Date
14th of April 2005
200 Day MA
74.1249
50 Day MA
64.0324
Beta
1.515
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in DexCom Stock, it is important to understand the factors that can impact its price. DexCom Inc secures Sharpe Ratio (or Efficiency) of -0.0156, which denotes the company had a -0.0156 % return per unit of risk over the last 3 months. DexCom Inc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm DexCom's Mean Deviation of 1.93, variance of 9.01, and Standard Deviation of 3.0 to check the risk estimate we provide.
At this time, DexCom's Total Stockholder Equity is very stable compared to the past year. As of the 20th of December 2025, Liabilities And Stockholders Equity is likely to grow to about 6.8 B, though Treasury Stock is likely to grow to (176.3 M). . At this time, DexCom's Price Earnings Ratio is very stable compared to the past year. As of the 20th of December 2025, Price Earnings To Growth Ratio is likely to grow to 41.29, while Price To Sales Ratio is likely to drop 7.41. DexCom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0156

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDXCM
Based on monthly moving average DexCom is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DexCom by adding DexCom to a well-diversified portfolio.
Price Book
9.4296
Enterprise Value Ebitda
20.4184
Price Sales
5.7366
Shares Float
387.4 M
Wall Street Target Price
85.2692

DexCom Stock Price History Chart

There are several ways to analyze DexCom Stock price data. The simplest method is using a basic DexCom candlestick price chart, which shows DexCom price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 23, 202571.06
Lowest PriceNovember 10, 202554.84

DexCom December 20, 2025 Stock Price Synopsis

Various analyses of DexCom's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell DexCom Stock. It can be used to describe the percentage change in the price of DexCom from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of DexCom Stock.
DexCom Price Daily Balance Of Power 0.12 
DexCom Price Action Indicator(0.12)
DexCom Accumulation Distribution 195,751 
DexCom Price Rate Of Daily Change 1.00 

DexCom December 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in DexCom Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use DexCom intraday prices and daily technical indicators to check the level of noise trading in DexCom Stock and then apply it to test your longer-term investment strategies against DexCom.

DexCom Stock Price History Data

The price series of DexCom for the period between Sun, Sep 21, 2025 and Sat, Dec 20, 2025 has a statistical range of 21.6 with a coefficient of variation of 6.84. Under current investment horizon, the daily prices are spread out with arithmetic mean of 65.08. The median price for the last 90 days is 66.08. The company completed 4:1 stock split on 13th of June 2022.
OpenHighLowCloseVolume
12/19/2025
 66.29  66.87  65.64  66.06  10,642,179 
12/18/2025 66.31  66.67  65.56  65.91  3,721,272 
12/17/2025
 66.18  68.19  65.65  65.75  5,095,589 
12/16/2025 66.35  67.00  65.20  66.37  4,435,312 
12/15/2025 67.41  67.75  65.36  65.73  7,198,030 
12/12/2025 69.05  69.31  66.68  66.96  6,831,183 
12/11/2025 67.98  69.77  67.53  68.94  6,926,600 
12/10/2025 66.49  68.22  65.69  67.56  7,468,548 
12/09/2025 65.93  66.75  64.40  66.33  5,032,821 
12/08/2025
 65.32  66.04  64.00  65.62  4,633,886 
12/05/2025 65.38  66.75  65.15  65.49  3,854,600 
12/04/2025
 65.13  65.33  64.09  65.25  3,482,041 
12/03/2025
 64.43  65.16  64.09  64.85  3,710,800 
12/02/2025
 65.08  65.31  64.36  64.45  4,799,271 
12/01/2025 62.89  63.98  62.32  63.52  4,817,063 
11/28/2025
 62.57  63.95  62.23  63.47  2,254,800 
11/26/2025 61.31  63.08  61.08  62.53  3,664,887 
11/25/2025
 61.99  64.00  61.43  61.69  6,759,200 
11/24/2025
 60.38  62.85  60.07  62.21  5,745,150 
11/21/2025
 58.50  61.15  58.36  60.23  5,453,400 
11/20/2025
 59.72  60.74  58.29  58.42  4,779,861 
11/19/2025
 59.78  60.33  59.16  59.73  6,353,100 
11/18/2025
 58.35  60.48  58.14  60.17  6,449,152 
11/17/2025
 58.23  59.15  57.20  58.49  5,818,911 
11/14/2025
 59.06  59.47  57.92  58.06  5,373,317 
11/13/2025
 59.20  60.85  59.20  59.72  6,563,690 
11/12/2025
 58.07  59.79  57.51  59.61  6,839,386 
11/11/2025
 56.29  58.86  55.84  58.13  9,740,206 
11/10/2025
 55.16  55.90  54.20  54.84  8,877,600 
11/07/2025
 57.95  58.25  54.11  55.00  10,462,643 
11/06/2025
 58.97  60.00  56.89  58.02  8,984,013 
11/05/2025
 60.95  60.95  58.34  59.28  8,964,957 
11/04/2025
 61.09  62.39  58.88  61.18  11,197,456 
11/03/2025
 58.61  61.15  58.53  60.43  17,445,551 
10/31/2025
 59.23  60.36  56.45  58.22  26,473,803 
10/30/2025
 68.36  69.17  68.00  68.20  6,759,023 
10/29/2025
 68.92  69.10  67.80  68.18  4,432,354 
10/28/2025
 70.58  70.58  66.42  69.23  8,565,009 
10/27/2025
 70.94  71.11  69.82  70.63  2,608,040 
10/24/2025 71.15  72.07  70.31  70.33  3,117,413 
10/23/2025
 70.70  71.47  70.11  71.06  2,855,777 
10/22/2025
 70.43  71.96  69.75  70.70  4,079,095 
10/21/2025
 68.76  69.83  67.99  69.75  4,473,468 
10/20/2025
 67.00  68.47  66.70  68.43  4,503,402 
10/17/2025
 66.26  66.85  65.41  66.60  3,516,331 
10/16/2025
 66.00  66.68  64.99  66.33  3,773,463 
10/15/2025
 66.35  66.61  64.90  65.41  3,333,161 
10/14/2025
 63.80  67.29  63.20  66.21  5,710,254 
10/13/2025
 65.99  66.37  64.93  65.20  3,303,372 
10/10/2025
 68.15  68.50  65.03  65.12  3,283,544 
10/09/2025
 67.56  69.00  67.24  68.08  3,342,682 
10/08/2025
 65.97  67.88  64.90  67.78  5,834,864 
10/07/2025
 66.77  67.42  65.89  66.03  3,558,248 
10/06/2025
 67.90  68.00  66.12  66.36  5,894,980 
10/03/2025
 66.80  67.63  66.37  67.05  4,435,483 
10/02/2025
 65.79  66.82  64.67  66.44  4,671,303 
10/01/2025
 67.21  67.86  63.53  66.08  7,619,500 
09/30/2025
 66.70  67.61  66.18  67.29  3,793,030 
09/29/2025
 67.34  67.37  65.18  66.46  5,868,000 
09/26/2025
 68.05  69.25  66.71  67.10  7,430,200 
09/25/2025
 66.71  68.57  65.50  68.30  6,457,229 

About DexCom Stock history

DexCom investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DexCom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DexCom Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DexCom stock prices may prove useful in developing a viable investing in DexCom
Last ReportedProjected for Next Year
Common Stock Shares Outstanding412.7 M254.7 M
Net Income Applicable To Common Shares392.4 M412 M

DexCom Quarterly Net Working Capital

1.88 Billion

DexCom Stock Technical Analysis

DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DexCom technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DexCom trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

DexCom Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for DexCom's price direction in advance. Along with the technical and fundamental analysis of DexCom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DexCom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in world development indicators.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.099
Earnings Share
1.8
Revenue Per Share
11.544
Quarterly Revenue Growth
0.216
Return On Assets
0.0702
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.